Launched on March 27, the second video of the series analyzes an article about a clinical trial of the association of lopinavir and ritonavir for the treatment of adults severely affected by COVID-19.
Video Script:
Marcelo Farina (Federal University of Santa Catarina, UFSC)
Project Coordination:
Débora Foguel (Federal University of Rio de Janeiro, UFRJ)
Video Production Team:
Lucia Bianconi (Federal University of Rio de Janeiro, UFRJ) – team leader
Amanda Kelen Soares Melo (Medicine student, Federal University of Rio de Janeiro, UFRJ)
Evaluation Committee:
Helena B. Nader (Vice-President, Brazilian Academy of Sciences, ABC)
João Batista Calixto (Vice-President for the South Region, Brazilian Academy of Sciences, ABC)
Mauro Teixeira (Vice-President for the Minas Gerais and Midwest Region, Brazilian Academy of Sciences, ABC)
Lucile Winter (Board of Directors, Brazilian Society for the Advancement of Science, SBPC)
Watch the Video (in Portuguese):
Reference:
“Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020 Mar 18. doi: 10.1056/NEJMoa2001282. [Epub ahead of print] PubMed PMID: 32187464; PubMed Central PMCID: PMC7121492. Cao et al.”
